AXSM - Axsome Kapitalizatsiyaning sotish hajmiga nisbati
EV/Revenue koeffitsienti savdolarning bozor qiymatini vizuallashtiradi, bunda 8.80 ushbu metrikaning joriy qiymatini ko'rsatadi. Axsome Therapeutics (AXSM) modeli kengaytiriluvchan hisoblanadi: noyob dori vositalarining chiqarilishi yuqori marjalar bilan global taqsimotni ta'minlaydi. Strategiya markaziy nerv tizimi (CNS) davolash uchun molekulalarni qayta yo'naltirishga asoslangan bo'lib, bu narxlarni belgilash imkoniyatini yaratadi. Axsome Therapeutics (AXSM) hozirda migren va depressiya segmentlaridagi ishtirokini kengaytirmoqda, bu esa bemorlar oqimini oshirmoqda.
Axsome Therapeutics Inc (AXSM) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi haqida ma'lumot:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Axsome Therapeutics|AXSM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Axsome Corp|AXSM - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati Axsome Therapeutics Inc|AXSM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Axsome Therapeutics|Tezkor likvidlik koeffitsiyenti axsome.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
AXSM - Sof daromad|Kelajakdagi sof foyda Axsome Therapeutics|AXSM - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Axsome|AXSM - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Axsome Therapeutics Inc|AXSM - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Axsome Therapeutics|AXSM - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi axsome.com|AXSM - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Axsome Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:axsome.com - AXSM
Nevrologik dori vositalarining maxsus iqlim nazorat qilinadigan kanallar orqali ishonchli taqsimoti Axsome Therapeutics (AXSM) uchun daromadning barqaror o'sishini ta'minlaydi. Bozor kapitalizatsiyasining yillik savdo hajmi nisbatini aks ettiruvchi joriy P/S baholashi biznes qiymatini haqiqiy pul oqimlari bilan solishtirish imkonini beradi, bu esa investorlarga aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlashga va kech kirish risklarini potentsial daromadlar bilan muvozanatlashga yordam beradi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Neurocrine Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati RGC (Regencell Bioscience Ltd)|ACADIA Pharmaceuticals Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati XENE (Xenon Corp)|VKTX: P/S multiplikatori|Sotuvga nisbatan narx supernus.com (SUPN)|Narxning daromadga nisbati Catalyst Pharmaceuticals, Inc.|DNLI: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HRMY|P/S multiplikatori Biohaven Corp (BHVN)|Narxning daromadga nisbati Amylyx Pharmaceuticals AMLX|TRVI (trevitherapeutics.com) - Narxning sotuvga nisbati|Praxis Precision Medicines, Inc. - P/S multiplikatori|Sotuvga nisbatan narx Anavex|CBLL (CeriBell Corp) - Kapitalizatsiyaning daromadga nisbati|Prothena Corp (PRTA) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ALEC|ANNX (annexonbio.com) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori OMER|Narx/daromad koeffitsiyenti Neurogene Inc|P/S multiplikatori ACIU (AC Immune Corp)|VYGR - Kapitalizatsiyaning daromadga nisbati|NMRA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti scilexholding.com SCLX|TVGN: P/S multiplikatori|Alpha Cognition Inc. (ACOG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CGTX|Kapitalizatsiya va daromad nisbati IKT (Inhibikase Pharma)|Narxning daromadga nisbati Cassava Sciences, Inc. (SAVA)|Narx/daromad koeffitsiyenti assertiotx.com|Narxning daromadga nisbati Coya Therapeutics COYA|VTGN - Kapitalizatsiyaning daromadga nisbati|OVID - Narxning daromadga nisbati|ABOS (Acumen Pharmaceuticals, Inc) - Kapitalizatsiya va daromad nisbati|CRVO: P/S multiplikatori|Sotuvga nisbatan narx Alterity Therapeutics Limited (ATHE)|Kapitalizatsiyaning daromadga nisbati CLNN|P/S multiplikatori PepGen Corp|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD (Relmada Corp) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Annovis Bio, Inc. ANVS|Grace Therapeutics Inc (GRCE) - Sotuvga nisbatan narx|Firefly Neuroscience - P/S multiplikatori|KLTO - P/S multiplikatori|NRSN (neurosense-tx.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati RVPH|Narxning daromadga nisbati MetaVia Inc.|neuraxis.com (NRXS) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Helius Medical (HSDT)|PASG - Sotuvga nisbatan narx|Narxning daromadga nisbati Neuphoria Therapeutics NEUP|NERV - Kapitalizatsiyaning daromadga nisbati|Athira Pharma, Inc. - P/S multiplikatori|Sotuvga nisbatan narx addextherapeutics.com|ALZN (alzamend.com) - Kapitalizatsiyaning daromadga nisbati|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA (Pasithea) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori CRGT|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|Cara Therapeutics Inc. (CARA) - Sotuvga nisbatan narx|CHRO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ELYM (Eliem Therapeutics)|ITCI: P/S multiplikatori|longboardpharma.com (LBPH) - P/S multiplikatori|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGen Biotech Inc - Narxning sotuvga nisbati|P/S multiplikatori NRBO|SAGE - Sotuvga nisbatan narx|Synaptogenix, Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori trevena.com TRVN|VIGL: Kapitalizatsiyaning daromadga nisbati|anewmeds.com - Kapitalizatsiyaning sotish hajmiga nisbati|CERE: P/S multiplikatori
